← All stocks

TransMedics Group, Inc.

TMDX Net buying

CIK 0001756262 #1701 in the set updated 17 Sep 2026

Bought (1 mo)

$109.06K

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$109.06K

+$109.06K against sales at will

By person

14 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Weill David

Director

$109.06K (1)

—

+$109.06K

16,392

0.0473%

$1.34M

+52.7%

Hassanein Waleed H

President & CEO

—

666,102

1.92%

$54.37M

+25.4%

Kania Edwin

Director

—

263,732

0.7606%

$21.53M

+2.0%

Corcoran Nicholas

See remarks

—

41,558

0.1198%

$3.39M

+96.9%

Khayal Tamer I

Chief Commercial Officer

—

36,042

0.1039%

$2.94M

+72.9%

Hernandez Gerardo

Chief Financial Officer

—

31,935

0.0921%

$2.61M

—

Cecere Giovanni

Chief Commercial Officer

—

19,057

0.0550%

$1.56M

+139.0%

Gunderson Thomas J.

Director

—

16,642

0.0480%

$1.36M

+764.5%

Forsyth Matthew S.

See Remarks

—

15,409

0.0444%

$1.26M

—

Ranganath Anil P.

See remarks

—

13,091

0.0378%

$1.07M

+45.3%

RAINES MERILEE

Director

—

6,981

0.0201%

$569.86K

+262.6%

TOBIN JAMES R

Director

—

6,981

0.0201%

$569.86K

−65.0%

Lovell Stephanie

Director

—

5,788

0.0167%

$472.47K

+200.7%

Basile Edward M

Director

—

5,788

0.0167%

$472.47K

+690.7%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 18,000

History held since 6 May 2019